BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 22564708)

  • 21. FT011, a new anti-fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy.
    Zhang Y; Edgley AJ; Cox AJ; Powell AK; Wang B; Kompa AR; Stapleton DI; Zammit SC; Williams SJ; Krum H; Gilbert RE; Kelly DJ
    Eur J Heart Fail; 2012 May; 14(5):549-62. PubMed ID: 22417655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy.
    Pan Y; Wang Y; Zhao Y; Peng K; Li W; Wang Y; Zhang J; Zhou S; Liu Q; Li X; Cai L; Liang G
    Diabetes; 2014 Oct; 63(10):3497-511. PubMed ID: 24848068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
    Liu X; Guo B; Zhang W; Ma B; Li Y
    J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of inflammatory response by a novel chalcone protects kidney and heart from hyperglycemia-induced injuries in type 1 diabetic mice.
    Fang Q; Wang J; Wang L; Zhang Y; Yin H; Li Y; Tong C; Liang G; Zheng C
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):179-91. PubMed ID: 26206226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
    Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes.
    Fiordaliso F; Cuccovillo I; Bianchi R; Bai A; Doni M; Salio M; De Angelis N; Ghezzi P; Latini R; Masson S
    Life Sci; 2006 Jun; 79(2):121-9. PubMed ID: 16445948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy.
    Tschöpe C; Walther T; Escher F; Spillmann F; Du J; Altmann C; Schimke I; Bader M; Sanchez-Ferrer CF; Schultheiss HP; Noutsias M
    FASEB J; 2005 Dec; 19(14):2057-9. PubMed ID: 16129698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling.
    Stilli D; Lagrasta C; Berni R; Bocchi L; Savi M; Delucchi F; Graiani G; Monica M; Maestri R; Baruffi S; Rossi S; Macchi E; Musso E; Quaini F
    Basic Res Cardiol; 2007 Nov; 102(6):488-99. PubMed ID: 17585379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats.
    Wang XT; Gong Y; Zhou B; Yang JJ; Cheng Y; Zhao JG; Qi MY
    Biomed Pharmacother; 2018 Jan; 97():1461-1467. PubMed ID: 29156537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus.
    Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K
    Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats.
    Yu BC; Chang CK; Ou HY; Cheng KC; Cheng JT
    Cardiovasc Res; 2008 Oct; 80(1):78-87. PubMed ID: 18573863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Icariin reduces mitochondrial oxidative stress injury in diabetic rat hearts].
    Bao H; Chen L
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1503-7. PubMed ID: 22779187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of vitamin A and insulin on the antioxidative state of diabetic rat heart: a comparison study with combination treatment.
    Zobali F; Avci A; Canbolat O; Karasu C
    Cell Biochem Funct; 2002 Jun; 20(2):75-80. PubMed ID: 11979500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes.
    Guo S; Meng XW; Yang XS; Liu XF; Ou-Yang CH; Liu C
    Acta Pharmacol Sin; 2018 Feb; 39(2):195-204. PubMed ID: 28905939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of chelerythrine on the hypertrophy of cardiac myocytes of neonatal rats induced by different glucose levels and its mechanism].
    Zhang WB; Wang M; Zhou BQ; Zhu JH; Fu GS
    Yao Xue Xue Bao; 2009 Feb; 44(2):115-20. PubMed ID: 19408678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.
    Riad A; Unger D; Du J; Westermann D; Mohr Z; Sobirey M; Dorenkamp M; Schultheiss HP; Tschöpe C
    Eur J Pharmacol; 2007 Jan; 554(1):40-5. PubMed ID: 17097634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling.
    De Blasio MJ; Huynh K; Qin C; Rosli S; Kiriazis H; Ayer A; Cemerlang N; Stocker R; Du XJ; McMullen JR; Ritchie RH
    Free Radic Biol Med; 2015 Oct; 87():137-47. PubMed ID: 25937176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.